Retour
Fourchette du Jour
212,60 €
219,18 €
Fourchette 52 Semaines
124,06 €
248,60 €
Volume
253 600
Moyenne 50J / 200J
225,73 €
/
202,09 €
Clôture Précédente
218,06 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -60,4 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -31,7 | 3,8 |
| Rev Growth 5Y % | 207,1 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
287,17 €
+33.2%
Low: 250,00 €
High: 342,00 €
P/E Prévisionnel
51,7
BPA Prévisionnel
4,22 €
Croissance BPA (est.)
+0,0%
CA Est.
1,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
23,00 €
19,34 € – 26,46 €
|
3,4 B | 5 |
| FY2029 |
20,07 €
16,87 € – 23,08 €
|
3,1 B | 2 |
| FY2028 |
15,87 €
10,83 € – 21,46 €
|
2,5 B | 7 |
Points Clés
Revenue grew 207,09% annually over 5 years — strong growth
Generating 43,62M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 116,87%
Capital efficient — spends only 1,18% of revenue on capex
Croissance
Revenue Growth (5Y)
207,09%
Revenue (1Y)90,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-13,85%
Net Margin-31,67%
Op. Margin-18,92%
Sécurité
Debt / Equity
N/A
Current Ratio1,04
Interest Coverage-1,69
Valorisation
P/E Ratio
-60,40
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90,22% | Revenue Growth (3Y) | 61,04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 207,09% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 691,71M | Net Income (TTM) | -219,03M |
| ROE | N/A | ROA | -16,82% |
| Gross Margin | 85,08% | Operating Margin | -18,92% |
| Net Margin | -31,67% | Free Cash Flow (TTM) | 43,62M |
| ROIC | -13,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,04 |
| Interest Coverage | -1,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -60,40 | P/B Ratio | N/A |
| P/S Ratio | 19,13 | PEG Ratio | 1,13 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 13,23B | Enterprise Value | 13,49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 691,71M | 363,64M | 266,72M | 51,17M | 7,78M |
| Net Income | -219,03M | -378,08M | -481,45M | -583,19M | -383,58M |
| EPS (Diluted) | -3,62 | -6,53 | -8,55 | -10,40 | -7,00 |
| Gross Profit | 588,53M | 319,38M | 222,32M | 39,04M | 4,26M |
| Operating Income | -130,89M | -278,76M | -455,54M | -561,81M | -451,79M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,30B | 1,18B | 825,59M | 1,09B | 1,08B |
| Total Liabilities | 1,46B | 1,29B | 971,28M | 826,39M | 201,29M |
| Shareholders' Equity | -162,75M | -105,71M | -145,70M | 263,35M | 883,64M |
| Total Debt | 871,41M | 856,62M | 743,06M | 617,57M | 209,92M |
| Cash & Equivalents | 615,78M | 559,54M | 392,16M | 444,77M | 446,27M |
| Current Assets | 1,11B | 1,06B | 702,72M | 923,47M | 805,89M |
| Current Liabilities | 1,07B | 907,86M | 736,51M | 716,78M | 100,36M |